Cibus Inc (CBUS)
Cibus Inc. is a Nasdaq-listed common stock company focused on agricultural biotechnology. It develops and licenses gene-edited plant traits designed to help farmers increase yields while reducing reliance on chemicals such as fungicides, insecticides, and fertilizers. The company also promotes sustainable ingredient applications through its technology platform. Cibus’s core intellectual property includes RTDS, a patented gene-editing system marketed as Trait Machine, which is described as a scalable, standardized, end-to-end, semi-automated, and high-throughput platform. The company was incorporated in 2010, formerly operated under the name Calyxt, Inc., and adopted the Cibus, Inc. name in June 2023. Its headquarters are in San Diego, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CBUS
|
$1.70
|
-7.9% Downside
|
Fair
|
$14.67
|
692.8% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-1.4x
|
4.0x
|
32.9x
|
134.3 M
|
387 M
|
67.3%
|
74.9%
|
-22.9
|
—
|
49.9%
|
